Overview
Keratosis follicularis spinulosa decalvans (KFSD), also known as Siemens syndrome or keratosis pilaris decalvans, is a rare inherited skin disorder belonging to the group of keratosis pilaris atrophicans conditions. It primarily affects the hair follicles, leading to widespread follicular hyperkeratosis (rough, spiny bumps around hair follicles), progressive scarring alopecia (permanent hair loss) of the scalp, and loss of eyebrows and eyelashes. The condition typically begins in infancy or early childhood with keratosis pilaris-like lesions on the face and body, followed by progressive cicatricial alopecia of the scalp that worsens over time. KFSD predominantly affects the skin, hair, and eyes. Ocular involvement is common and may include photophobia (light sensitivity), blepharitis, and corneal dystrophy. The follicular keratotic papules can be widespread, affecting the face, neck, trunk, and extremities. Males tend to be more severely affected than females, consistent with the X-linked inheritance pattern. The condition is caused by mutations in the MBTPS2 gene (also known as SAT-1), located on the X chromosome, which encodes a membrane-bound transcription factor protease involved in cholesterol and fatty acid metabolism. There is currently no cure for KFSD. Treatment is symptomatic and supportive. Topical keratolytics (such as urea-based creams or salicylic acid) and emollients may help manage the follicular hyperkeratosis. Topical or oral retinoids have been used with variable success to reduce keratotic lesions, though they do not prevent progressive hair loss. Anti-inflammatory treatments may help manage scalp inflammation. Ophthalmologic monitoring is recommended for patients with eye involvement. Early dermatologic and genetic counseling is advised for affected families.
Clinical phenotype terms— hover any for plain English:
X-linked recessive
Carried on the X chromosome; typically affects males more than females
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for Keratosis follicularis spinulosa decalvans.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Keratosis follicularis spinulosa decalvans at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Keratosis follicularis spinulosa decalvans.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Keratosis follicularis spinulosa decalvans.
Community
No community posts yet. Be the first to share your experience with Keratosis follicularis spinulosa decalvans.
Start the conversation →Latest news about Keratosis follicularis spinulosa decalvans
No recent news articles for Keratosis follicularis spinulosa decalvans.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Keratosis follicularis spinulosa decalvans
What is Keratosis follicularis spinulosa decalvans?
Keratosis follicularis spinulosa decalvans (KFSD), also known as Siemens syndrome or keratosis pilaris decalvans, is a rare inherited skin disorder belonging to the group of keratosis pilaris atrophicans conditions. It primarily affects the hair follicles, leading to widespread follicular hyperkeratosis (rough, spiny bumps around hair follicles), progressive scarring alopecia (permanent hair loss) of the scalp, and loss of eyebrows and eyelashes. The condition typically begins in infancy or early childhood with keratosis pilaris-like lesions on the face and body, followed by progressive cicatr
How is Keratosis follicularis spinulosa decalvans inherited?
Keratosis follicularis spinulosa decalvans follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Keratosis follicularis spinulosa decalvans typically begin?
Typical onset of Keratosis follicularis spinulosa decalvans is infantile. Age of onset can vary across affected individuals.